Latest FdaApproval News and Updates : FdaApproval updates, FdaApproval News , FdaApproval around the world

Nishadil

Washington | 20°C (overcast clouds)

Why Korean Sunscreens Outshine U.S. Options: The Case for Bemotrizinol

Top story

Why Korean Sunscreens Outshine U.S. Options: The Case for Bemotrizinol

In focus

Latest feed

Barriers May Keep Merck’s New Cholesterol Pill From Success

Sun Protection Gets a Boost: Meet the New Ingredient Changing Sunscreen

A Game Changer for Cholesterol? FDA Greenlights New Daily Pill Lipfendra

FDA Greenlights First Oral PCSK9 Inhibitor – Lipfendra

Latest headlines

A Pill, Not a Shot: FDA Clears Merck’s First Oral PCSK9 Inhibitor

A Pill, Not a Shot: FDA Clears Merck’s First Oral PCSK9 Inhibitor

From Tragedy to Triumph: How Kiran Mazumdar‑Shaw Turned Personal Loss into a Global Biosimilar Breakthrough

From Tragedy to Triumph: How Kiran Mazumdar‑Shaw Turned Personal Loss into a Global Biosimilar Breakthrough

How a Personal Tragedy Drove Kiran Mazumdar‑Shaw to Pioneer Cancer Biosimilars at Biocon

How a Personal Tragedy Drove Kiran Mazumdar‑Shaw to Pioneer Cancer Biosimilars at Biocon

Stoke Therapeutics’ Dravet‑Syndrome Gene Therapy Nears the Finish Line

Stoke Therapeutics’ Dravet‑Syndrome Gene Therapy Nears the Finish Line

A Game-Changer in Heart Health: FDA Approves First-Ever Oral Pill to Tackle Stubborn Cholesterol

A Game-Changer in Heart Health: FDA Approves First-Ever Oral Pill to Tackle Stubborn Cholesterol

A New Dawn for Heart Health: FDA Greenlights Game-Changing Oral Cholesterol Pill

A New Dawn for Heart Health: FDA Greenlights Game-Changing Oral Cholesterol Pill

A Betrayal of Trust: The Alarming Tale of Aduhelm's Flawed Approval

A Betrayal of Trust: The Alarming Tale of Aduhelm's Flawed Approval

Viridian Therapeutics’ LUMVOA Gets FDA Nod, Poised for Market Debut

Viridian Therapeutics’ LUMVOA Gets FDA Nod, Poised for Market Debut

A Game Changer? Wockhardt's Zaynich Secures Landmark US FDA Nod for Stubborn UTIs

A Game Changer? Wockhardt's Zaynich Secures Landmark US FDA Nod for Stubborn UTIs

Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials

Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials

Dexcom’s New G7 CGM Shows Real‑World Benefits for Type 2 Diabetes

Dexcom’s New G7 CGM Shows Real‑World Benefits for Type 2 Diabetes

AkeSO’s Lung‑Cancer Drug Shows a Survival Edge Over the Current Standard

AkeSO’s Lung‑Cancer Drug Shows a Survival Edge Over the Current Standard

Mobia Medical's Rocky Start: Navigating the Treacherous Waters of Stroke Treatment

Mobia Medical's Rocky Start: Navigating the Treacherous Waters of Stroke Treatment

Mifepristone and the Courts: Decoding the Abortion Pill's Legal Rollercoaster

Mifepristone and the Courts: Decoding the Abortion Pill's Legal Rollercoaster

The Unfolding Legal Battle Over Mifepristone: A Closer Look at America's Most Common Abortion Pill

The Unfolding Legal Battle Over Mifepristone: A Closer Look at America's Most Common Abortion Pill

A New Era for Hearing: Gene Therapy Approved for Inherited Deafness

A New Era for Hearing: Gene Therapy Approved for Inherited Deafness

UCLA Shines as FDA Approves Groundbreaking Gene Therapy for Children

UCLA Shines as FDA Approves Groundbreaking Gene Therapy for Children

A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!

A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!

A New Chapter in Lupus Nephritis Care: Aurinia's Breakthrough

A New Chapter in Lupus Nephritis Care: Aurinia's Breakthrough

A New Dawn for Fragile Lives: Abeona Therapeutics' Zevaskyn Revenue Signals a Profound Shift

A New Dawn for Fragile Lives: Abeona Therapeutics' Zevaskyn Revenue Signals a Profound Shift

Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off

Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off

ImmunityBio's Stock Plunge: Can Dr. Soon-Shiong's Cancer Science Convince Skeptical Investors?

ImmunityBio's Stock Plunge: Can Dr. Soon-Shiong's Cancer Science Convince Skeptical Investors?

The Ozempic War is Over: What the Novo Nordisk and Hims & Hers Settlement Means for Your Access to GLP-1s

The Ozempic War is Over: What the Novo Nordisk and Hims & Hers Settlement Means for Your Access to GLP-1s

A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval

A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval

A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar

A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar

The Shifting Sands of Pharma: FDA's Grip, Global Ambitions, and the Future of Medicine

The Shifting Sands of Pharma: FDA's Grip, Global Ambitions, and the Future of Medicine

A Legal Storm Brews: Sarepta's Groundbreaking Muscular Dystrophy Therapy Faces Renewed Patent Challenge

A Legal Storm Brews: Sarepta's Groundbreaking Muscular Dystrophy Therapy Faces Renewed Patent Challenge

A New Horizon for Schizophrenia Treatment

A New Horizon for Schizophrenia Treatment

Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag

Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag

A New Era for Flu Protection? Moderna's mRNA Vaccine on the Horizon

A New Era for Flu Protection? Moderna's mRNA Vaccine on the Horizon

Weight-Loss Drug Wars Escalate: Novo Nordisk Sues Hims & Hers Over Compounded Semaglutide

Weight-Loss Drug Wars Escalate: Novo Nordisk Sues Hims & Hers Over Compounded Semaglutide

Hims & Hers' Super Bowl Cancer Test Ad Sparks Heated Debate Over Reliability and Ethics

Hims & Hers' Super Bowl Cancer Test Ad Sparks Heated Debate Over Reliability and Ethics

A Pivotal Moment: Protalix Biotherapeutics Stands on the Cusp of a Game-Changing Decision for Elfabrio

A Pivotal Moment: Protalix Biotherapeutics Stands on the Cusp of a Game-Changing Decision for Elfabrio

Legend Biotech's Carvykti: A Beacon of Hope Reshaping Multiple Myeloma Treatment

Legend Biotech's Carvykti: A Beacon of Hope Reshaping Multiple Myeloma Treatment

Prime: Unlocking a Brighter Future for Wilson's Disease and Beyond

Prime: Unlocking a Brighter Future for Wilson's Disease and Beyond

A New Dawn in Oncology: Grail's Quest for Multi-Cancer Early Detection

A New Dawn in Oncology: Grail's Quest for Multi-Cancer Early Detection

FDA Approval for Cytokinetics' Aficamten: A Scientific Triumph, But Wall Street Remains Wary

FDA Approval for Cytokinetics' Aficamten: A Scientific Triumph, But Wall Street Remains Wary

Cytokinetics' Myqorzo Secures Landmark FDA Approval, Reshaping HCM Treatment Landscape

Cytokinetics' Myqorzo Secures Landmark FDA Approval, Reshaping HCM Treatment Landscape

Load more